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CIB1 (CIB) is an EF-hand-containing protein that
binds multiple effector proteins, including the platelet
IIb3 integrin and several serine/threonine kinases
and potentially modulates their function. The crystal
structure for Ca2-bound CIB1 has been determined at
2.0 Å resolution and reveals a compact -helical protein
containing four EF-hands, the last two of which bind
calcium ions in the standard fashion seen in many other
EF-hand proteins. CIB1 shares high structural similar-
ity with calcineurin B and the neuronal calcium sensor
(NCS) family of EF-hand-containing proteins. Most im-
portantly, like calcineurin B and NCS proteins, which
possess a large hydrophobic pocket necessary for ligand
binding, CIB1 contains a hydrophobic pocket that has
been implicated in ligand binding by previous muta-
tional analysis. However, unlike several NCS proteins,
Ca2-bound CIB1 is largely monomeric whether bound
to a relevant peptide ligand or ligand-free. Differences
in structure, oligomeric state, and phylogeny define a
new family of CIB1-related proteins that extends from
arthropods to humans.
One important mechanism by which cells respond to changes
in Ca2 levels involves the activation of EF-hand proteins, such
as calmodulin. Upon Ca2 binding, these proteins undergo
structural changes that allow them to bind and activate target
proteins. At least two specific structural changes can occur in
EF-hand-containing proteins due to Ca2 binding that facili-
tate signal transduction. The first type of change occurs when
a hydrophobic binding pocket becomes accessible, thus facili-
tating ligand binding. The second type of change, termed a
myristoyl switch, involves the extrusion of an N-terminal myr-
istoyl group from a hydrophobic cavity in the protein, thereby
leading to membrane localization, as described in recoverin (1)
and related proteins.
Recoverin and related proteins are termed neuronal calcium
sensors (NCS)1 due to their neuronal expression pattern and
high degree of homology (2). These proteins have a variety of
functions; recoverin directly inhibits rhodopsin kinase (3),
while a subgroup of NCS proteins that includes frequenin
modulates synaptic activity, neurotransmitter release, and ves-
icle secretion (2). NCS proteins bind Ca2 at levels just above
basal Ca2 concentrations and reach half maximal binding
below 1 M free Ca2, which is a 10-fold higher affinity than
that of calmodulin (4). Therefore, these proteins are fully active
at intracellular Ca2 concentrations that activate only a small
fraction of calmodulin.
CIB1 (CIB, calmyrin, and KIP) is an EF-hand-containing
protein that possesses many features of NCS proteins. CIB1
contains four EF-hand domains (denoted EF1–4), two of which
bind Ca2 (EF3 and EF4) with affinities of 1.9 and 0.54 M,
respectively (5). These values are comparable to the Ca2 af-
finities seen in NCS proteins. In addition, CIB1 is N-terminally
myristoylated (6), although it is unknown whether it functions
as a Ca2-myristoyl switch, despite sequence similarity in its
myristoyl-binding pocket to the Ca2-myristoyl switch protein
recoverin (7, 8). The myristoyl group of CIB1 may target it to
membranes, since CIB1 fractionates exclusively with mem-
brane fractions in both nucleated (6) and non-nucleated (9)
cells. Moreover, disruption of myristoylation by addition of an
N-terminal myc tag causes CIB1 staining to shift from mem-
branes to a diffuse cytosolic and nuclear pattern (6). However,
myristoylation does not appear to be required for CIB1 binding
to its ligands (9, 10).
Unlike NCS proteins, CIB1 is not exclusively neuronal, but is
widely expressed (9). Moreover, CIB1 is less homologous in
sequence to several NCS proteins, such as KChIP1 (46%), neu-
rocalcin (46%), and frequenin (43%) than they are to one an-
other (2). In fact, CIB1 is more homologous to the EF-hand
proteins calcineurin B (57% similarity) and calmodulin (54%).
CIB1 was originally identified in a yeast two-hybrid screen as
a binding partner for the cytoplasmic tail of the platelet inte-
grin IIb (11). Subsequently, additional CIB1-binding proteins
were identified, including DNA-dependent protein kinase (12),
the polo-like kinases Fnk and Snk (13), Rac3 (10), Pax3 (14),
and presenilin 2 (6), and CIB1 has been shown to modify the
function of some of these proteins (14, 15).
Integrins are heterodimeric cell adhesion receptors containing
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an  and  subunit that can exist in a resting conformation on
unactivated cells and convert to an active conformation upon cell
stimulation, resulting in a conformational change that allows the
integrin to bind its adhesive protein ligands with higher affinity.
The IIb3 integrin is expressed only on platelets and their
precursors, megakaryocytes, and is the most abundant integrin
on these cells. CIB1 binding to IIb appears to modulate the
activation state of the integrin (16, 17), platelet spreading (18),
and FAK activation (19). The CIB1 binding region of IIb has
been delineated, and corresponds to a membrane-proximal por-
tion of the cytoplasmic tail, including several amino acids within
the putative transmembrane domain (7). These binding residues
of IIb are likely to form an amphipathic -helix (20, 21), which
agrees with data showing that the hydrophobic crevices of EF-
hand-containing proteins bind -helical regions, such as the
binding of calcineurin B to calcineurin A (22) and the binding of
KChIP1 to the Kv4.2 channel (23).
The sequences of three CIB1 homologs (CIB2, -3, and -4) are
also found in the human genome. CIB1 and some of its ho-
mologs have been identified in other vertebrates, and highly
homologous sequences are present in the genome of more sim-
ple organisms such as Drosophila melanogaster. Sequence
analysis indicates CIB1 and its homologs form a protein family
distinct from those of the calcineurin B and the NCS families.
To help determine the molecular mechanism for CIB1 binding
to its various targets, we describe the x-ray crystal structure of
Ca2-bound CIB1 to 2.0 Å.
MATERIALS AND METHODS
Protein Purification—Human wild type CIB1 and CIB1 1–8 (resi-
dues 9–191), each fused to an N-terminal hexahistidine tag, were
expressed from pProEX HTc (Invitrogen) in Escherichia coli BL21(DE3)
cells. The final DNA sequence includes a hexahistidine Ni-affinity tag
followed by a tobacco etch virus cleavage site at the N terminus; the tag
was later removed from the protein as described below. CIB1 1–8 was
used for crystallization experiments. Wild-type CIB1 was used for gel
filtration and analytical ultracentrifugation experiments.
Expression of CIB1 was initiated by inoculating 1 liter of LB broth
with 100 ml of overnight culture and incubating at 37 °C. CIB1 expres-
sion was induced after 4 h by the addition of isopropyl 1-thio--D-
galactopyranoside to a final concentration of 1 mM, and cells were
incubated for an additional 3 h at 37 °C. Cells were centrifuged at
2000  g for 20 min and resuspended in Buffer A, composed of 20 mM
Tris, 10 mM imidazole, 100 mM NaCl, 10% (v/v) glycerol, and 100 M
CaCl2 (pH 7.5) with 1 tablet of “Complete EDTA-free protease inhibitor
mixture” (Roche Applied Science). Cells were lysed by one pass through
an EmulsiFlex-C5 (Avestin) homogenizer, and lysed cells were centri-
fuged at 200,000  g for 40 min. Clarified cell lysate was loaded onto
two 5-ml Hi-Trap chelating HP columns in series (Amersham Bio-
sciences) that had been preloaded with 100 mM NiSO4 and equilibrated
with buffer. The column was washed with 5 and 30% of Buffer B (Buffer
A plus 1 M imidazole) and CIB1 was eluted at 40% of this buffer.
Fractions containing CIB1 were pooled and dialyzed 1 h in 20 mM Tris,
10 mM NaCl, 10% (v/v) glycerol, and 100 M CaCl2 (pH 7.5) to dilute the
imidazole and remove residual Ni2. Dialysis and removal of the His
tag was performed by overnight incubation with 4 ml of tobacco etch
virus (purified as stated previously (24)) in dialysis buffer that also
contains 5 mM dithiothreitol. Analysis of the extent of cleavage was
performed by analyzing samples by SDS-PAGE. If additional cleavage
was required, further incubation with additional tobacco etch virus was
performed. CIB1 was further purified by an S-200 gel filtration column
(Amersham Biosciences) equilibrated with 20 mM Tris, 150 mM NaCl,
and 5 mM dithiothreitol (pH 7.5). Fractions were analyzed by SDS-
PAGE, and the purest fractions were concentrated using a Vivaspin 10
MWCO concentrator (Vivascience, Hannover, Germany), and the buffer
was exchanged to 20 mM MES, pH 6.5, 10 mM NaCl, 2 mM dithiothreitol
(pH 6.5) by several rounds of dilution and concentration. Protein was
frozen in 50-l aliquots at 30 mg/ml. Quantities of 40–50 mg of protein
were obtained per liter of broth.
Crystallization—Crystals of purified CIB1 1–8 were obtained by
sitting drop vapor diffusion at 18 °C for 3–5 days by equilibrating
against 20 mM Bis-Tris propane, 300 mM calcium acetate, and 18%
polyethylene glycol 3350 (pH 6.8) and reached full size after 10 days.
Crystals were cryoprotected by slowly equilibrating the crystal drop to
glycerol in increments of 2%, 4%, 6%, 8%, 10%, 15%, and 20% (v/v)
glycerol in the mother liquor solution, followed by flash freezing in
liquid nitrogen.
Gel Filtration—The Low Molecular Weight Gel Filtration Calibra-
tion Kit (Amersham Biosciences) was used to calibrate a Superdex S-75
gel filtration column (Amersham Biosciences) according to the manu-
facturer’s instructions. Briefly, 200 l each of ovalbumin (43 kDa) and
ribonuclease A (13.7 kDa) at 5 mg/ml or albumin (67 kDa) and chymot-
rypsinogen A (25 kDa) were loaded onto a column pre-equilibrated with
S-75 buffer (20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, and
2 mM calcium acetate) at 0.8 ml/min. The void volume (Vo) was deter-
mined by the elution volume of blue dextran (2000 kDa). Purified
full-length CIB1 (250 l of 4 mg/ml) was loaded onto the column that
had been pre-equilibrated with 2 mM calcium acetate or 2 mM EGTA.
The cytoplasmic IIb peptide (Ac-LVLAMWKVGFFKRNRPPLEED-
DEEGQ-COOH) was added to CIB1 in a molar ratio of 2:1, with 200 l
of CIB1 (65 M) and 100 l of IIb (146 M) loaded.
Analytical Ultracentrifugation—Purified full-length CIB1 was equil-
ibrated to AUC buffer (20 mM Tris, pH 7.5, 150 mM NaCl, and either 2
mM (CH3COO)2Ca or 2 mM EGTA) using a Vivaspin 10 MWCO concen-
trator (Vivascience, Hannover, Germany). The final concentrations of
CIB1 were 230, 180, and 80 M, with A280 values of 0.6, 0.4, and
0.2. For experiments with the cytoplasmic IIb peptide (Ac-LVLAM-
WKVGFFKRNRPPLEEDDEEGQ-COOH), a 1:1 molar ratio of IIb to
CIB1 was used. Equivalent concentrations of IIb peptide were used in
the sample and reference cells. Prior to centrifugation, impurities of the
IIb peptide were eliminated by performing a buffer exchange in a
stirred cell (Amicon) with a 1,000 NMWL Ultrafiltration Membrane
(Millipore) of regenerated cellulose. Analytical ultracentrifugation was
performed using a Beckman Optima XL-I Ultracentrifuge, a Ti-60 rotor
and a 6-sector cell (1.2-cm path length). For CIB1 protein alone, sam-
ples were centrifuged at 16,000 rpm for 26 h at 20 °C. Offset was
determined by meniscus depletion by centrifugation at 45,000 rpm for
6 h. For CIB1 plus IIb samples, centrifugation was performed at
16,000 rpm for 32 h at 20 °C, and offset was determined by centrifuga-
tion at 40,000 rpm for 8 h. Equilibrium was determined to have been
reached when data collected every 2 h did not change from the previous
reading. Data were fit using XL-A/XL-1 Data Analysis Software Version
4.0 (Beckman Instruments, Inc., 1997) using values of 0.736 for the
partial specific volume and 1.0 for solvent density.
Data Collection—The data used for phasing by single-wavelength
anomalous diffraction were collected from a single crystal of CIB1 on a
Rigaku RU-H3R rotating anode x-ray generator fitted with a chromium
anode and Osmic VariMax-Cr optics, which together generate CrK
radiation (  2.29 Å) and a Rigaku R-AXIS IV imaging plate area
detector. Chromium K radiation is more suitable than CuK (  1.54
Å) for detecting the dispersion signal from intrinsic elements such as
calcium and sulfur of CIB1 protein, because the signal is doubled
(ƒ  2.51 e and ƒ  1.14 e, respectively) compared with that of
CuK (ƒ  1.29 e
 and ƒ  0.56 e, respectively). The VariMax-Cr
was equipped with a slit that allowed the divergence to be tuned for the
sample. This slit setting was optimized by maximizing I/(I) on equiv-
alent screening images. The crystal was mounted in an arbitrary ori-
entation, and data were collected at cryogenic temperatures in a single
continuous scan. Both incident and diffracted beam helium beam paths
were used to minimize air absorption and scattering. Data collection
statistics are given in Table I.
For phasing, we collected 510° of data to ensure high redundancy for
the calcium and sulfur anomalous signal, although with the chromium
wavelength x-rays, this much redundancy is probably not necessary
(25). Data were processed with HKL2000 (42), which has an absorption
correction that is needed for the longer wavelength chromium x-rays
(25). Due to the longer wavelength and the necessity to use the R-AXIS
IV detector with a 300-mm image plate width, the crystal-to-detector
distance was 122 mm, and the maximum resolution for this data set
was 2.7 Å. The structure was refined against data collected from an-
other crystal collected at the SER-CAT beamline at the Advanced
Proton Source at 1.0 Å wavelength; this crystal diffracted to 2.0 Å.
Structure Determination and Refinement—Calculation of the Mat-
thews coefficient indicated two CIB1 molecules per asymmetric unit in
the P21 cell. The program SOLVE (26) was used to locate the positions
of anomalous scatterers from the chromium data. We used the “single-
wavelength anomalous diffraction” script (to 3.0 Å) provided on the
SOLVE website to search for the eight highest peaks, reasoning that
these might correspond to individual calcium ions (with a higher f  at
2.2909 Å compared with sulfur) bound to each of the EF-hands in the
asymmetric unit. SOLVE easily found eight sites with occupancies
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ranging from 0.147 to 0.522. The overall Z score from SOLVE was 30.9,
and the figure of merit was 0.39. Only two C-terminal EF-hands per
CIB1 monomer are occupied by individual calcium ions. There are,
however, two more calcium ions per CIB1 monomer that bind at surface
positions and are most likely due to the high Ca2 concentration (300
mM) in the crystallization medium. That gives a total of eight calcium
ions in the asymmetric unit. The top eight sites found by SOLVE were
not all calcium ions; three were sulfur atoms.
The program RESOLVE (27) was used to find non-crystallographic
symmetry and carry out “statistical” solvent flattening. Three pairs of
the eight sites were related by NCS, and the “overlap of NCS-related
density” was 0.76 in RESOLVE. The solvent-flattened electron density
map from RESOLVE was used to trace the chain of one of the two
monomers of CIB1 in the asymmetric unit. The process was guided by
the structure of calcineurin B (PDB code 1TCO), which is 57% homol-
ogous to CIB1. The sequence in the helices surrounding the EF-hands
was matched easily to density; however, the density in the EF-hand
loops was not as continuous and clear. An anomalous difference Fourier
map using the phases from the eight SOLVE sites produced a new set
of sites, which turned out to be sulfur and lower occupancy calcium
atoms. The chain tracing was verified using the sulfur sites from cys-
teine and methionine residues. Once a preliminary model of the first
molecule in the asymmetric unit was built, molecular replacement
using the CCP4 program AMoRe (28) was used to position the second
molecule. The independently determined positions of calcium and sul-
fur atoms determined by SOLVE verified this solution.
The density for the second molecule is significantly weaker, espe-
cially in the second half of the molecule that contains the two EF-hand
calcium ions. The temperature factors for this molecule in initial rounds
of conjugate gradient or simulated annealing refinement using CNS
(29) were quite high (average temperature factors for all atoms in
molecules 1 and 2 were typically 40 and 70 Å2, respectively). Rfree
values were just below 30% for these refinements, using either the 2.0
Å data set collected at the synchrotron, or the chromium data set to 2.8
Å. If the packing is inspected, the second molecule (“B”) has fewer
intermolecular contacts in the crystal, apparently giving it a more
flexible position and thereby more average disorder as indicated by high
temperature factors. A TLS refinement using the CCP4 program Ref-
mac5 (43) to 2.0 Å using each subunit and its associated calcium ions as
a TLS “group,” and using tight geometrical restraints (matrix diagonal
weighting term  0.05), gave a model with Rwork  21.2% and Rfree 
25.7%. The r.m.s. bond and angle deviations were 0.01 Å and 1.10°,
respectively. From the Ramachandran plot, 2 (0.6%) and 1 residues
(0.3%) were found in generously allowed and forbidden regions, respec-
tively; however, these residues were either at the N terminus (residues
13 and 14 in molecule A) or neighboring a disordered loop (residue 146
in molecule B) where the density is poor.
Sequence Alignment—Sequences represented in Fig. 3B were aligned
using ClustalX (30), and the output guide tree file was imported and
displayed as a dendrogram using the program TreeView 1.6.6
(taxonomy.zoology.gla.ac.uk/rod/rod.html).
RESULTS AND DISCUSSION
Overall Structure of CIB1 and Geometry of Ca2 Binding—
Full-length CIB1 consistently yielded twinned, poorly formed
crystals. Because proteins homologous to CIB1, such as recov-
erin, have a disordered N terminus (31), and secondary struc-
ture suggests that this region is also disordered in CIB1, CIB1
1–8 was used for crystallization and structure determination.
FIG. 1. Electron density map, overall fold, and EF-hand geometry of CIB1. A, electron density from EF-hand 4 in CIB1. The 2Fo  Fc
electron density omit map (shown in stereo; contoured to 1 ) was calculated by removing all atoms within 10.0 Å of the coordinating Ca2 ion.
Highlighted are the seven ligands that coordinate the calcium ion with a pentagonal bipyramidal geometry typical of EF-hands. Equatorial ligands
include the side-chain carboxylates of Asp-161, Asp-163, Asp-165, and Glu-172 and the carbonyl oxygen (O) of Thr-167, while axial ligands are
provided by the remaining oxygen of the carboxylate group of Glu-172 and a water molecule. B, ribbon diagram of the overall fold of CIB1 showing
the positions of the high affinity Ca2 ions (gold spheres) bound to EF-hands 3 and 4. Regions are color-coded: N-terminal region and EF1 are blue,
EF2 is yellow, EF3 is red, EF4 is green, and the C-terminal helix is purple. Helices as well as the termini are labeled; a dotted line indicates the
disordered loop between helices H7 and H8. C, ribbon diagram of EF-hands 1 through 4, underneath which are worm diagrams of the EF-hands
showing individual amino acids involved in Ca2 binding for EF3 and EF4, and possible Ca2 binding amino acids based on their position (positions
1, 3, 5, 7, 12, and 13) in the EF2 loop. Because the conformation of EF1 is degenerate, no worm figure is shown. In this diagram, relevant protein
oxygens and waters are red. Dashed lines indicate calcium ligation or hydrogen bonding.
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The structure of CIB1 was solved by single-wavelength anom-
alous diffraction phasing using chromium radiation (  2.29
Å, Rigaku/MSC Inc., The Woodlands, TX). These data were
collected to 2.7 Å, but phases were eventually extended to 2.0 Å
using native data sets collected both in-house and at the SER-
CAT beamline at Advanced Photon Source (Argonne, IL). There
are two molecules of CIB1 in the asymmetric unit. The electron
density (Fig. 1A) has been fit with models of CIB1 encompass-
ing residues 12–191 except for a disordered loop between res-
idues 137 and 142 in molecule A and 136–145 in molecule B.
The overall fold of CIB1 is shown in Fig. 1B and is very
similar to other Ca2-binding proteins containing four EF-
hands, such as calmodulin and calcineurin B. However, we
observed that only EF-hands 3 and 4 of CIB1 bind Ca2 (Fig. 1,
B and C), as previously demonstrated by NMR (5). Calcium
ions bind canonical EF-hands with high affinity due to acidic
residues at positions 1, 3, 5, and 12, where residues at positions
1, 3, and 5 contribute individual ligands to the coordination
sphere and the residue at position 12 contributes two ligands
(32). In most EF-hands, a backbone carbonyl at position 7 as
well as a water molecule that is hydrogen-bonded to a side-
chain oxygen from position 7 complete the coordination sphere,
yielding a pentagonal bipyramidal geometry. In EF4 of CIB1
(Fig. 1C), the side chains of Asp-161 (position 1), Asp-163,
Asp-165, and Glu-172 (position 12) coordinate Ca2, with Glu-
172 being a bidentate ligand. Thr-167 (position 7) ligates Ca2
through its carbonyl oxygen and also coordinates a water mol-
ecule that ligates Ca2. Similarly, in EF3 (Fig. 1C), the Ca2 is
coordinated by the side chains of Asp-116 (position 1), Asp-118,
Asp-120, and Asp-127 as well as the carbonyl of Thr-122 (po-
sition 7) and two water molecules. One ligating water molecule
is bridged through an additional water molecule interacting
with the side chain of Thr-122, and the other ligating water
molecule is seen in only one molecule of the asymmetric unit. In
EF4, this water molecule is replaced by the bidentate ligation
of Glu-172 (position 12). Relative to EF4, the ligation sphere of
the Ca2 in EF3 is less well ordered, which is consistent with
the fact that EF3 binds Ca2 with a lower affinity than EF4 (5).
Calcium ions are not bound in EF1 and EF2. It is not sur-
prising that Ca2 is absent from EF1, because it has an addi-
tional eight amino acids within the loop that normally binds
Ca2. Following this extended loop region in EF1, the helix
that typically corresponds to the second helix in an EF-hand is
kinked at Pro-62, a residue conserved in calmodulin and cal-
cineurin B, thereby creating two smaller helices (H3a and H3b)
(Fig. 1C). EF2 is less radically modified from a canonical EF-
hand domain. For example, many of the residues (positions 1,
3, and 5) within the loop that are typically acidic and chelate
calcium ions have been replaced with serine or alanine. The
EF2 loop also contains 13 residues rather than 12, with the
extra residue, Pro-82, inserted after position 3.
A high concentration of Ca2 (300 mM calcium acetate) was
necessary for crystallization, presumably explaining why each
monomer of CIB1 binds an additional two Ca2 ions in posi-
tions not typically associated with EF-hand domains (see Table
I). There are six water molecules in the octahedral coordination
sphere of each of these Ca2 ions, indicating that both binding
events are of low affinity and most likely not biologically rele-
vant, which is consistent with previous binding data (5).
The helices of EF-hands reorient in relation to one another
when Ca2 is bound (33). The interhelical angle between the E
and F helices is used as a measure of whether these helices
display a Ca2-bound (open) conformation or a Ca2-free
(closed) conformation. In a closed conformation, E and F helices
are close to one another and the interhelical angle (180°  ) is
large. In an open conformation, when Ca2 is present, the E
TABLE I
Data collection and refinement
Data collection
Source Chromium APS
 (Å) 2.29 1.00
Space group P21 P21
Unit cell
(Å) 56.61, 50.98, 77.13 56.66, 51.01, 77.21
(°) 90, 103.128, 90 90, 103.12, 90
Rotation range (°) 510 360
Resolution (Å) 40–2.6 40–2.0
Reflections 633,650 589,209
Unique reflections 12,013 29,442
R(I)merge
a (%) 4.6 (12.6)b 5.8 (23.4)
Completeness (%) 94.1 (88.1) 95.4 (81.0)
Redundancy 10.4 (8.4) 7.3 (6.2)
	I/(I)
 54.0 (14.5) 32 (5.8)
Data processing HKL2000 HKL2000




Refinement and model statistics
Resolution (Å) 40–2.0
Number of protein atoms 2781 (2 molecules/A.U.)






r.m.s.d. bonds (Å) 0.01
r.m.s.d. angles (°) 1.10
Ramachandran plot
% in most favored regions 92.5
% in additional allowed regions 6.6
% in disallowed regions 0.3
a R(I)merge  100  ¥hklI  	I
/¥hkl	I
, where I is the observed intensity and 	I
 is the average intensity from observations of symmetry related
reflections, respectively.
b Values in parentheses are for the outermost resolution shell.
c A.U., asymmetric unit(s).
d Rcryst and Rfree  100  Fo  Fc/Fo, where 5% of the reflections were held aside for Rfree throughout refinement.
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and F helices are typically farther apart and the interhelical
angle is smaller. For example, Ca2-free calmodulin has inter-
helical angles between 130° and 140°, whereas Ca2-bound
calmodulin has interhelical angles between 85° and 100° (23).
To determine whether the EF-hands of CIB1 displayed an open
or closed conformation, we calculated the interhelical angles
using the program interhlx (33). EF2, EF3, and EF4 of CIB1
display similar interhelical angles, with values of 116.4°,
113.2°, and 111.5°, respectively. Because these angles are so
similar, they indicate that EF2, which does not contain Ca2,
adopts an open conformation like those of Ca2-bound EF3 and
EF4. This open conformation is maintained by hydrogen bonds
across the EF2 loop involving residues that typically bind Ca2
(positions 1, 3, 7, and 13). EF1, which is highly degenerate, has
an interhelical angle of 125.5°, which is indicative of a more
closed conformation.
CIB1 and Its Structural Relationship to Other EF-hand-
containing Proteins—To compare the structure of CIB1 to other
EF-hand-containing proteins, the coordinates of CIB1 (the first
molecule in the asymmetric unit) were compared with other
proteins in the Protein Data Bank using MSD-fold (www.ebi.
ac.uk/msd-srv/ssm/). As expected, a number of mammalian
EF-hand-containing proteins showed significant homology to
CIB1, the two most significant being calcineurin B (PDB code
1TCO, Z-score of 5.2, r.m.s.d. of 2.5 Å over 136 residues, 27%
sequence identity) and KChIP1 (Z-score of 3.9, r.m.s.d. of 2.6 Å
over 136 residues, 24% sequence identity). The structural
alignment of these proteins based on the output from MSD-fold
is shown in Fig. 2 (A and B). In addition to these proteins, an
Arabidopsis protein (AtCBL2, PDB code 1UHN) (34) was found
to have strong structural homology to CIB1 (Z-score of 5.1,
r.m.s.d. of 2.4 Å over 137 residues, 24% sequence identity). This
protein is part of a distinct calcineurin B-like family of Arabi-
dopsis proteins that interact with a novel family of plant serine/
threonine protein kinases (35).
Although CIB1 closely aligns to other EF-hand-containing
proteins in EF2, EF3, and EF4, significant differences appear
within EF1 and the N-terminal region. As stated previously,
CIB1 contains a long insertion within the EF1 loop that is not
found in any of the structures of EF-hand-containing proteins
solved to date, including calcineurin B and KChIP1. The geom-
etries of helices H3a and H3b (Fig. 1C), including the bend of
the helices due to the proline residue described previously, are
recapitulated in calcineurin B (Fig. 2A), but not in KChIP1
(Fig. 2B); this proline residue causes a kink in these helices
that is also conserved in calmodulin. However, due to the large
insertion in the EF1 loop, helices H3a and H3b in CIB1 do not
superimpose on the equivalent helices in calcineurin B, despite
the similar proline-induced helical break.
The N-terminal regions of calcineurin B and NCS proteins
point away from the center of the molecule, but the equivalent
portion of CIB1 points to the center of the protein and forms a
number of interactions with helix H5 and H6 (Fig. 2). As crystal
packing interactions also occur in this region and the temper-
ature factors for the N terminus are generally higher than in
the helices of the EF-hands, it is not clear if this conformation
of the N terminus is biologically significant.
Finally, the C terminus of CIB1 forms an -helix that is
similar in position to the C-terminal helix of KChIP1 (Fig. 2).
Because the C terminus plays an important role in target
recognition both in calcineurin B and in KChIP1, this region
will be discussed in greater detail in a later section (“Potential
Ligand Binding Site of CIB1”).
Sequence Alignment—Several proteins in the sequence data
base from arthropods to humans share significant sequence ho-
mology to CIB1. Three proteins in humans with high homology to
CIB1 are CIB2 (also known as KIP2), CIB3 (also known as KIP3),
and CIB4, which share 59%, 62%, and 64% similarity, respec-
tively. There is currently no published data on CIB3, and only the
expression profile and chromosomal location have been deter-
mined for CIB2 (36). CIB4 (NCBI accession number XP_059399)
is named by the present authors based on a sequence from
automated computational analysis of the human genome.
Based on the sequence alignment (Fig. 3A), all CIB homologs
have a large insertion within EF1, strongly suggesting that
this EF-hand cannot bind Ca2 in any of the CIB homologs.
Similarly, all CIB homologs contain a proline equivalent to
Pro-62 of CIB1 that causes a kink between helices H3a and
H3b (Fig. 3A), which is important for the overall structure of
the hydrophobic binding pocket (see subsequent section). How-
ever, one notable difference among CIB homologs is that the
EF2 loop (between helices H4 and H5) of CIB2 and CIB3
contains more acidic residues than CIB1, indicating that CIB2
and CIB3 may each bind an additional Ca2 ion within this
region. Differences in the number of bound Ca2 ions among
homologous proteins are not surprising, in that differences in
Ca2 stoichiometry are observed among members of the NCS
family. For example, KChIP1 binds Ca2 ions in EF-hands 3
and 4 (23), recoverin binds Ca2 ions in EF-hands 2 and 3 (1),
and frequenin binds Ca2 ions in EF-hands 2, 3 and 4 (37).
The dendrogram in Fig. 3B depicts the sequence relatedness
of CIB1 and its homologs, as well as a number of other mam-
malian Ca2-binding proteins. From this analysis, we conclude
that CIB-like proteins, found in species from arthropods to
humans, form a family distinct from both the calcineurin B-like
and NCS proteins. Members of the CIB family share closest
FIG. 2. Superposition of CIB1 with its closest structural ho-
mologs. A, superposition of CIB1 with calcineurin B (PDB code 1TCO)
B, superposition of CIB1 with KChIP1 (PDB code 1S6C). N and C
termini are labeled, and the different regions are colored according to
the scheme in Fig. 1, with the ribbons for calcineurin B and KChIP1
being semi-transparent.
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FIG. 3. Relationship of CIB1 with some of its nearest homologs. A, sequence alignment of CIB1 with its three human homologs (CIB2,
CIB3, and CIB4), calcineurin B and two NCS proteins, KChIP1 and frequenin. Alignment of CIB1 with CIB2, CIB3, and CIB4 was performed using
ClustalX (30) and then merged with the structural alignment from MSD-fold (www.ebi.ac.uk/msd-srv/ssm/) of CIB1 with calcineurin B (PDB code
1TCO), KChIP1 (PDB code 1S6C), and human frequenin (PDB code 1G8I). The positions of helices (red tubes), loop regions (gray lines), and
disordered regions (gray dotted lines) in the CIB1 structure are shown above the alignment, and every tenth residue in CIB1 is marked by a dot
above the alignment. Residues in CIB1 involved in Ca2 binding are colored red, and residues that correspond to the CIB1 hydrophobic binding
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homology to calcineurin B and its relatives, but sequence ho-
mology is still quite low between CIB family members and
calcineurin B (30% sequence identity). Among the four hu-
man CIB proteins, CIB2 and CIB3 are more ancestral, because
CIB proteins from Drosophila melanogaster, Anopheles gam-
biae, and Danio rerio more strongly resemble these proteins.
Oligomeric State of CIB1—Many NCS homologs of CIB1
form dimers or tetramers under various conditions. For in-
stance, KChIP3 tends to form tetramers at protein concentra-
tions higher than 20 M and stable dimers at low protein
concentrations (38). Similarly, neurocalcin forms a dimer in the
crystal (39) and in solution when Ca2 is present (40) but forms
a monomer when Ca2 is absent (40). Conversely, GCAP-2
forms dimers in the absence of Ca2 and monomers in the
presence of Ca2 (40). Also, unmyristoylated recoverin forms a
dimer within the asymmetric unit of the crystal structure (31),
whereas KChIP1 also forms dimers, but only in the presence of
ligand (23). Residues involved in KChIP1 dimerization are
poorly conserved in CIB1 (Fig. 3A).
To determine whether CIB1 forms oligomers in the presence
or absence of Ca2 and ligand, we first performed gel filtration
(Fig. 4A). In the presence of Ca2, CIB1 eluted at a volume
corresponding to 30.6 kDa, which is larger than its molecular
mass of 21.7 kDa, but smaller than the expected size of a dimer,
which would be 43.4 kDa (Fig. 4A). The anomalous elution
volume of CIB1 may be accounted for by the fact that gel
filtration columns are typically calibrated using spherical pro-
teins as standards, while EF-hand-containing proteins have a
more oblong “dumbbell-shape.” Similarly, GCAP-2, which has a
molecular mass of 23.8 kDa, exhibits an anomalous elution
volume, with the monomer eluting at 30.6 kDa and the dimer
eluting at 57 kDa (40). Apo-CIB1, or CIB1 in the absence of
Ca2, elutes at 32.5 kDa, consistent with NMR data of apo-
CIB1, which displays a conformation that is more extended
than that of Ca2-CIB1 (5). An extended conformation is also
seen in Ca2-free recoverin, as opposed to its more compact
conformation when Ca2 is present (1). Ca2-CIB1 in the pres-
ence of the entire IIb cytoplasmic peptide eluted at 35 kDa,
which is representative of the molecular mass of monomeric
CIB1 plus the molecular mass of the peptide (3.1 kDa).
To confirm the gel filtration results, we performed sedimen-
tation equilibrium of purified recombinant full-length CIB1 in
the presence of either 2 mM (CH3COO)2Ca or 2 mM EGTA by
analytical ultracentrifugation (AUC). These experiments were
also performed in the presence of the IIb peptide, with high,
medium, and low concentrations of CIB1 as described under
“Experimental Procedures.” Molecular weight determinations
are given for the intermediate concentration (150–190 M), and
the other concentrations give similar results. The AUC data fit
to a molecular mass for Ca2-CIB1 of 26.9 kDa compared with
a calculated value of 21.7 kDa, with an offset of 0.05 (Fig. 4B).
This indicates an equilibrium favoring monomers with the
pocket (see Fig. 5) and that are involved in dimerization in rat KChIP1 (PDB code 1SC6) are highlighted with brown and green circles, respectively.
B, evolutionary relationship of CIB1 with other Ca2-binding proteins. The dendrogram (derived as described under “Experimental Procedures”)
is colored to highlight the distinct families of CIB-like proteins (purple), calcineurin B-like proteins (blue), and NCS proteins (green). The proteins
are human unless otherwise stated, and their NCBI accession numbers are included.
FIG. 4. CIB1 primarily forms monomers in the presence or absence of Ca2 and the IIb cytoplasmic domain. A, elution profiles of
apo-CIB1, Ca2-CIB1, and Ca2-CIB1 plus IIb cytoplasmic tail peptide were determined using a Superdex S-75 column (Amersham Biosciences).
The molecular mass standards used were albumin (67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa), and ribonuclease A (13.7 kDa).
The elution volume (Ve) of blue dextran was used to determined the void volume (Vo). B, sedimentation equilibrium data of Ca
2-CIB1, apo-CIB1,
and Ca2-CIB1 plus IIb by analytical ultracentrifugation. Molecular weights fit using a one-state model are posted on each graph.
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ability to form dimers for a small percentage of molecules. The
molecular mass from AUC for apo-CIB1 was 23.6 kDa, with an
offset of 0.021, indicating a population almost entirely mono-
meric. To determine whether Ca2-CIB1 forms dimers in the
presence of ligand, we performed experiments with equivalent
concentrations of IIb peptide in the sample and reference
cells. The molecular mass determined from AUC was 25.5 kDa
(offset of 0.255), compared with a calculated molecular mass
for a 1:1 CIB1-peptide complex of 24.8 kDa, indicating the
prevalence of a 1:1 complex of CIB1 and IIb. The high offset
values obtained for experiments with IIb are indicative of the
difficulty in precisely matching the IIb concentration in the
reference and sample cells. Taken together, these data indicate
that CIB1, unlike NCS proteins, remains monomeric in the
presence and absence of Ca2 and ligand.
Potential Ligand Binding Site of CIB1—EF-hand-containing
proteins contain hydrophobic pockets that bind the am-
phipathic -helices of their ligands. These binding pockets exist
on the opposite side of the molecule from the Ca2-binding sites
of EF-hands 3 and 4. In Fig. 5, the molecular surfaces of CIB1,
KChIP1, and calcineurin B are colored by hydrophobic poten-
tial, and the positions of the portions of calcineurin A and Kv4.2
bound in calcineurin B and KChIP1, respectively, are traced.
Residues within the hydrophobic binding pocket of CIB1 are
denoted in the sequence alignment on Fig. 3A.
In the case of calcineurin B, calcineurin A binds in a
hydrophobic channel formed from residues in helices H1, H2,
H3, and H7 (equivalent to H1, H3, H4, and H8 in CIB1) and
the C-terminal region (see Fig. 5) (22). In KChIP1, the Kv4.2
peptide binds as a continuation of the C-terminal helix H10
in a hydrophobic channel formed by EF1 and EF2 (23). Helix
H10 of KChIP1 is in a similar position to the C-terminal helix
of CIB1. Similarly placed hydrophobic channels have been
found in other NCS proteins (37, 39, 41), although structures
of these proteins with their ligands have not yet been
reported.
CIB1 contains a large hydrophobic channel just following the
C terminus of the molecule, as in KChIP1, but the binding
pocket is considerably narrower than that of KChIP1. This is in
part due to the bend at Pro-61 and the associated position of
helix H3b, which pushes further into the hydrophobic binding
pocket relative to the similar helix in KChIP1. Binding studies
have shown that CIB1 binds to a minimal 15-amino acid region
of integrin IIb (7), which corresponds to four -helical turns.
This channel (18 Å across) would be too small to bind four
turns of an -helix (25 Å). However, this hydrophobic channel
continues, albeit in a narrower form, on either side of the H10
helix, so residues within this C-terminal helix could also be
important in peptide binding. Indeed, it has been demonstrated
that residues within this C-terminal helix (17) are critical for
CIB1 binding to the IIb cytoplasmic tail. In addition, prior to
this structure, a homology model of CIB1 was generated (7)
based on the structure of calcineurin B bound to calcineurin A
(PDB code 1TCO). Based on this model, four residues (Leu-115,
Leu-131, Ile-153, and Phe-173) were mutated and found to
affect IIb integrin binding without grossly affecting the CIB1
structure (as measured by circular dichroism). In our structure,
these residues are buried under helix H10 and are thus not
surface-accessible. However, loss of integrin binding via
these mutations may be explained by their causing local
movements of helix H10, which then would affect the struc-
ture of the hydrophobic binding groove. Another possibility is
that upon integrin binding, helix H10 undergoes a conforma-
tional change such that a larger ligand binding groove is
formed. In the structure of the Arabidopsis EF-hand-
containing protein AtCLB2 (34), the C terminus completely
covers the hydrophobic binding groove, and consequently it
has been suggested that, upon ligand binding, the C terminus
is released from this groove. For CIB1, these studies indicate
the importance of the hydrophobic binding groove and the
H10 helix. Additional structural and mutational studies will
aid in further defining the role of this region in CIB1 binding
to effectors.
In conclusion, the crystal structure of CIB1 reveals signifi-
cant structural similarity to other EF-hand-containing proteins
and confirms that only EF-hands 3 and 4 bind Ca2 through
canonical interactions characteristic of EF-hand domains. The
major differences between CIB1 relative to the NCS and cal-
cineurin B families are in the overall structure of EF1 and the
N-terminal portions. The position of the C-terminal helix of
CIB1 is similar to that of KChIP1, and like KChIP1, CIB1
contains a hydrophobic binding pocket near this helix. This
hydrophobic binding pocket is likely to bind IIb and possibly
other targets; as shown previously, residues within this area
are critical for binding IIb (7). A family of proteins related to
CIB1 has been discovered that is distinct from its closest ho-
mologs, calcineurin B and the NCS protein family. Future
structural studies of CIB1 and CIB-family members with high
affinity binding peptides from target proteins such as integrin
FIG. 5. CIB1 contains a strongly hydrophobic channel that is
preserved in other EF-hand-containing proteins. Coordinates for
CIB1 (PDB code 1XO5), calcineurin B (PDB code 1TCO), and KChIP1
(PDB code 1S6C) were read by the program SYBYL version 6.9.1
(www.tripos.com), hydrogens were added, and MOLCAD molecular sur-
faces were generated and colored to represent the spectrum of hydro-
phobic potential (red, highly hydrophobic; blue, highly hydrophilic). The
orientation of CIB1 in this molecular surface representation is very
similar to that in Fig. 1B. The region of calcineurin A in contact with
calcineurin B, as well as the Kv4.2 peptide, are shown as helical worms
in the binding sites of calcineurin B and KChIP1, respectively, and their
boundaries are enumerated. Positions of the C termini of CIB1, cal-
cineurin B, and KChIP1 on these surfaces are labeled, as are selected
secondary structural elements.
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IIb, in combination with further biochemical and cellular as-
says, will extend our understanding of the role of this family of
proteins in cellular signaling.
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